Search

Author/Creator Hisamatsu, T

11. DOP86 Corticosteroid-sparing effects of ustekinumab therapy for Ulcerative Colitis through 3 years: UNIFI long-term extension. (27th May 2021)

Authors:
Scherl, E J; Rowbotham, D S; Danese, S; Sandborn, W J; Miao, Y; Zhang, H; Abreu, M T; Panaccione, R; Afif, W; Hisamatsu, T; Leong, R W; Arasaradnam, R P; Sands, B E; Marano, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. OP15 Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension. (30th January 2023)

Authors:
Danese, S; Afif, W; Abreu, M; Sandborn, W; Miao, Y; Zhang, H; Panaccione, R; Hisamatsu, T; Scherl, E; Leong, R; Rowbotham, D; Arasaradnam, R; Peyrin-Biroulet, L; Sands, B; Marano, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. OP23 The efficacy and safety of guselkumab induction therapy in patients with moderately to severely active Ulcerative Colitis: Phase 2b QUASAR Study results through week 12. (21st January 2022)

Authors:
Dignass, A; Rubin, D; Bressler, B; Huang, K H; Shipitofsky, N; Germinaro, M; Zhang, H; Johanns, J; Feagan, B; Sandborn, W; Sands, B; Hisamatsu, T; Lichtenstein, G; Panes, J; Allegretti, J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i025
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. OP24 Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's Disease: Week 48 analyses from the phase 2 GALAXI 1 study. (21st January 2022)

Authors:
Danese, S; Panaccione, R; Rubin, D T; Sands, B E; Reinisch, W; D'Haens, G; Panés, J; Gonzalez, S; Weisel, K; Sahoo, A; Frustaci, M E; Yang, Z; Sandborn, W J; Afzali, A; Hisamatsu, T; Andrews, J M; Feagan, B
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i026
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. OP26 Risankizumab induces early clinical remission and response in patients with Moderate-to-Severe Crohn's Disease: Results from the phase 3 ADVANCE and MOTIVATE studies. (27th May 2021)

Authors:
Schreiber, S W; Ferrante, M; Panaccione, R; Colombel, J F; Hisamatsu, T; Lim, A; Lindsay, J O; Rubin, D T; Sandborn, W J; Neimark, E; Song, A P; Liao, X; Feng, T; Berg, S; Wallace, K; D'Haens, G R
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S026
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. OP28 The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn's Disease: Results from the phase 2 GALAXI 1 study. (27th May 2021)

Authors:
Danese, S; Sandborn, W J; Feagan, B G; Weisel, K; Gonzalez, S; Frustaci, M E; Yang, Z; Johanns, J; Germinaro, M; Afzali, A; Andrews, J M; D'Haens, G; Hisamatsu, T; Panaccione, R; Reinisch, W; Rubin, D T; Sands, B E; Panes, J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S027
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. OP37 Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI. (25th January 2019)

Authors:
Sandborn, W J; Sands, B E; Panaccione, R; O'Brien, C D; Zhang, H; Johanns, J; Peyrin-Biroulet, L; Van Assche, G; Danese, S; Targan, S R; Abreu, M T; Hisamatsu, T; Szapary, P; Marano, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S025
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. P172 Clinical characteristics of newly diagnosed adult patients with Crohn's disease in Japan: Interim analysis of Inception cohort registry study of patients with Crohn's disease (iCREST-CD). (27th May 2021)

Authors:
Matsuoka, K; Fujii, T; Okamoto, R; Yamada, A; Kunisaki, R; Matsuura, M; Watanabe, K; Shiga, H; Takatsu, N; Bamba, S; Mikami, Y; Yamamoto, T; Shimoyama, T; Motoya, S; Torisu, T; Kobayashi, T; Ohmiya, N; Saruta, M; Matsuda, K; Matsumoto, T
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S246
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗